Varicella Zoster Immune Globulin (VZIG) from Japan
VZIG is human immune serum globulin containing antibodies to varicella-zoster virus for post-exposure prophylaxis in immunocompromised patients. It is classified under HTS 3002.12.0030 as human immune blood sera from donors with recent varicella infection or vaccination. Administered intramuscularly within 96 hours of exposure.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Provide evidence of donor VZV seropositivity; FDA lot-by-lot review mandatory
• Ship in validated frozen containers; monitor for freeze-thaw cycles
• Avoid bulk import without U.S. agent registration per plasma rules